The case for timely, affordable access to cannabis grows with more evidence and new discoveries.
Taken a step further, this notion logically leads to a discussion about medical-insurance coverage for cannabis medicine. Continue reading WHY INSURANCE COMPANIES MUST PAY FOR MEDICAL-CANNABIS EXPENSES
Diseases of the gastrointestinal system, including cancer, are linked to the endocannabinoid system in humans, say researchers from Austria and Germany. Continue reading Cannabinoids may be effective in preventing COLON CANCER and treating INFLAMMATORY BOWEL DISEASES
Experimental research out of Brazil has found that cannabinoids may be able to halt the growth and spread of glioblastoma, an aggressive and incurable form of brain cancer. Continue reading CANNABINOIDS HALT GROWTH AND SPREAD OF BRAIN CANCER
Cannabis treatment significantly improved challenging behaviours in children suffering Autism Spectrum Disorder (ASD), says a new study done in Israel and published in the March issue of Journal of Autism Developmental Disorders.
Continue reading FEWER OUTBURSTS IN KIDS WITH AUTISM AFTER CANNABIS TREATMENT
“Cannabis use appears to reverse the impact of the modern American diet …” Scientists are discovering the mysteries around obesity. Could cannabis be the secret cure? A deficiency of the body’s endocannabiniod system has been clearly linked to obesity for the first … Continue reading THC CURES OBESITY
For the first time, a clinical study has identified how CBD alters brain function in ways that may correlate with improvements in psychosis. “A dramatic change toward healthy … Continue reading CBD alters brain function to improve psychosis, says first-ever study
New research out of Los Angeles found that men who have sex with men and also use cannabis, but no other mind-altering drugs, had significantly fewer sexually transmitted infections, including HIV Continue reading Fewer STDs among men-who-have-sex-with-men and also use cannabis.
Canaccord Genuity Growth Corp. (CGG) yesterday provided an update on its agreement with Columbia Care, a leading medical cannabis company in the United States.
CGG has obtained approval to extend the Escrow Release Deadline, as per an amendment of the subscription receipt agreement terms. Continue reading Escrow-release deadline extended for Canaccord deal with Columbia Care
Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today. Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria. Continue reading Multiple clinical-trial records on negative aspects of cannabis were updated this week.